StonvexLoading…
StonvexStonvexStonvexCore line items from VALU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $25.44M | $17.16M | $8.61M | $35.08M |
Operating Income | $4.01M | $3.01M | $1.50M | $5.99M |
Net Income | $18.05M | $5.68M | $6.46M | $20.69M |
EPS (Diluted) | $1.92 | $1.29 | $0.69 | $2.20 |
Total Assets | $150.96M | $147.94M | $148.20M | $144.53M |
Total Liabilities | $43.20M | $42.45M | $45.17M | $44.85M |
Cash & Equivalents | $46.46M | $43.61M | $33.71M | $34.08M |
Free Cash Flow OCF − CapEx | $13.80M | $8.51M | $5.56M | $20.07M |
Shares Outstanding | 9.40M | 9.41M | 9.41M | 9.42M |